Cerebral apoplexy (stroke): pathogenesis, pathophysiology and therapy as illustrated by regional blood flow measurements in the brain.
D000628:Aminophylline / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D002245:Carbon Dioxide / Q000097:blood; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000628:therapy; D003911:Dextrans / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D006973:Hypertension; D006985:Hyperventilation; D007036:Hypothermia, Induced; D000860:Hypoxia / Q000097:blood; D002542:Intracranial Embolism and Thrombosis / Q000503:physiopathology; D002546:Ischemic Attack, Transient / Q000503:physiopathology; D008353:Mannitol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D001463:Barbiturates; D003911:Dextrans; D005730:Ganglionic Blockers; D005938:Glucocorticoids; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D000628:Aminophylline; D008353:Mannitol